Literature DB >> 91685

Two avian sarcoma virus mutants with defects in the DNA polymerase-RNase H complex.

K Moelling, R R Friis.   

Abstract

Two mutants of avian sarcoma virus which exhibit different phenotypes have been analyzed for the properties of their RNA-dependent DNA polymerase and RNase H activities. LA 338 is a complex multiple mutant with at least one lesioneach in transformation and replication functions. The purified RNA-dependent DNA polymerase-RNase H complex from the mutant is twofold more thermolabile than that from the wild-type parent. A peculiarity of this mutant is that the ability of the enzyme to respond to synthetic template-primers is lost more rapidly than is the response to native RNA as template. The mutant enzyme cannot be protected from inactivation by the addition of synthetic template-primers. LA 672 represents a different phenotype among reverse transciptase mutant, showing a "late"-acting block in replication which affects only production of progeny by infected cells grown at the nonpermissive temperature. The purified DNA polymerase-RNase H complex of LA 672 is not thermolabile; rather, progeny grown at the nonpermissive temperature yield purified enzyme with a 20-fold-reduced specific activity in both DNA polymerase and RNase H. The content of reverse transcriptase protein in such noninfectious progeny, furthermore, did not appear to be significantly diminished since immunologically active enzyme could be demonstrated in a competition test for anti-reverse transcriptase antibody and since beta and alpha subunits of reverse transcriptase could be identified after polyacrylamide gel electrophoresis of partially purified enzyme preparations. The amounts of beta and alpha from the mutant were about twofold lower.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91685      PMCID: PMC353567          DOI: 10.1128/JVI.32.2.370-378.1979

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  A VIRUS IN CHICK EMBRYOS WHICH INDUCES RESISTANCE IN VITRO TO INFECTION WITH ROUS SARCOMA VIRUS.

Authors:  H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1960-08       Impact factor: 11.205

2.  Characterization of a conditional mutant of Rouse sarcoma virus with alterations in early and late functions of cell transformation.

Authors:  J B Bookout; M M Sigel
Journal:  Virology       Date:  1975-10       Impact factor: 3.616

3.  Temperature-sensitive mutants of avian sarcoma viruses: genetic recombination between multiple or coordinate mutants and avian leukosis viruses.

Authors:  D G Blair; W S Mason; E Hunter; P K Vogt
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

4.  A mutant of Rous sarcoma virus with a thermolabile defect in the virus envelope.

Authors:  F Tato; J A Beamand; J A Wyke
Journal:  Virology       Date:  1978-07-01       Impact factor: 3.616

5.  Characterization of reverse transcriptase and RNase H from friend-murine leukemia virus.

Authors:  K Moelling
Journal:  Virology       Date:  1974-11       Impact factor: 3.616

6.  Determination of the defective function in two mutants of Rous sarcoma virus.

Authors:  W S Mason; R R Friis; M Linial; P K Vogt
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

7.  DNA polymerase activity from two temperature-sensitive mutants of Rous sarcoma virus is thermolabile.

Authors:  I M Verma; W S Mason; S D Drost; D Baltimore
Journal:  Nature       Date:  1974-09-06       Impact factor: 49.962

8.  Characterization of two conditional early mutants of Rous sarcoma virus.

Authors:  M Linial; W S Mason
Journal:  Virology       Date:  1973-05       Impact factor: 3.616

9.  Serological analysis of the deoxyribonucleic acid polymerase of avian oncornaviruses. II. Comparison of avian deoxyribonucleic acid polymerases.

Authors:  R C Nowinski; K F Watson; A Yaniv; S Spiegelman
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

10.  Serological analysis of the deoxyribonucleic acid polymerase of avian oncornaviruses. I. Preparation and characterization of monospecific antiserum with purified deoxyribonucleic acid polymerase.

Authors:  K E Watson; R C Nowinski; A Yaniv; S Spiegelman
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

View more
  2 in total

1.  Isolation of cloned Moloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity.

Authors:  M L Kotewicz; C M Sampson; J M D'Alessio; G F Gerard
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

2.  Rous sarcoma virus mutant LA3382 is defective in virion glycoprotein assembly.

Authors:  J M Hardwick; E Hunter
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.